Bifogade filer
Kurs & Likviditet
Kalender
Tid* | ||
2025-05-20 | 09:00 | Kvartalsrapport 2025-Q1 |
2025-05-20 | - | Årsstämma |
2025-02-25 | 08:00 | Bokslutskommuniké 2024 |
2024-11-19 | 09:00 | Kvartalsrapport 2024-Q3 |
2024-08-27 | - | Kvartalsrapport 2024-Q2 |
2024-05-22 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2024-05-21 | - | Årsstämma |
2024-05-21 | - | Kvartalsrapport 2024-Q1 |
2024-02-20 | - | Extra Bolagsstämma 2024 |
2024-02-20 | - | Bokslutskommuniké 2023 |
2023-11-10 | - | Kvartalsrapport 2023-Q3 |
2023-08-22 | - | Kvartalsrapport 2023-Q2 |
2023-05-24 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2023-05-23 | - | Årsstämma |
2023-05-23 | - | Kvartalsrapport 2023-Q1 |
2023-02-15 | - | Bokslutskommuniké 2022 |
2022-11-16 | - | Kvartalsrapport 2022-Q3 |
2022-08-23 | - | Kvartalsrapport 2022-Q2 |
2022-05-11 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2022-05-10 | - | Kvartalsrapport 2022-Q1 |
2022-05-10 | - | Årsstämma |
2022-03-29 | - | Extra Bolagsstämma 2022 |
2022-02-22 | - | Bokslutskommuniké 2021 |
2021-11-11 | - | Kvartalsrapport 2021-Q3 |
2021-07-13 | - | Kvartalsrapport 2021-Q2 |
2021-05-20 | - | Split SYNT 1:10 |
2021-05-12 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2021-05-11 | - | Årsstämma |
2021-05-11 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-11-12 | - | Kvartalsrapport 2020-Q3 |
2020-10-02 | - | X-dag ordinarie utdelning SYNT 1.50 SEK |
2020-07-14 | - | Kvartalsrapport 2020-Q2 |
2020-05-05 | - | Årsstämma |
2020-05-05 | - | Kvartalsrapport 2020-Q1 |
2020-02-27 | - | Bokslutskommuniké 2019 |
2019-11-12 | - | Kvartalsrapport 2019-Q3 |
2019-07-14 | - | Kvartalsrapport 2019-Q2 |
2019-04-30 | - | X-dag ordinarie utdelning SYNT 1.50 SEK |
2019-04-29 | - | Kvartalsrapport 2019-Q1 |
2019-04-29 | - | Årsstämma |
2019-02-27 | - | Bokslutskommuniké 2018 |
2018-11-16 | - | Kvartalsrapport 2018-Q3 |
2018-08-22 | - | Kvartalsrapport 2018-Q2 |
2018-04-26 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2018-04-25 | - | Kvartalsrapport 2018-Q1 |
2018-04-25 | - | Årsstämma |
2018-02-21 | - | Bokslutskommuniké 2017 |
2017-11-10 | - | Kvartalsrapport 2017-Q3 |
2017-08-24 | - | Kvartalsrapport 2017-Q2 |
2017-04-26 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2017-04-25 | - | Årsstämma |
2017-04-25 | - | Kvartalsrapport 2017-Q1 |
2017-02-15 | - | Bokslutskommuniké 2016 |
2016-10-28 | - | Kvartalsrapport 2016-Q3 |
2016-08-26 | - | Kvartalsrapport 2016-Q2 |
2016-04-27 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2016-04-26 | - | Årsstämma |
2016-04-26 | - | Kvartalsrapport 2016-Q1 |
2016-02-26 | - | Bokslutskommuniké 2015 |
2015-10-30 | - | Kvartalsrapport 2015-Q3 |
2015-08-28 | - | Kvartalsrapport 2015-Q2 |
2015-04-13 | - | Årsstämma |
2015-04-13 | - | Kvartalsrapport 2015-Q1 |
2015-02-17 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2015-02-13 | - | Bokslutskommuniké 2014 |
2014-11-28 | - | Kvartalsrapport 2014-Q3 |
2014-09-26 | - | Extra Bolagsstämma 2014 |
2014-08-29 | - | Kvartalsrapport 2014-Q2 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
At the extraordinary general meeting on February 20, 2024, it was decided to introduce the LTIP 2024 incentive program for staff in Sweden within SyntheticMR AB (publ) (hereinafter referred to as "the Company"), as well as the opportunity to subscribe for warrants of series TO 2. Furthermore, it was decided about TO 3, meaning an opportunity for an employee in the USA to subscribe for warrants of series TO 3. LTIP 2024 offers employees in the Company the opportunity to subscribe for shares, with accompanying share rights, at market value in a directed issue. The subscription price for shares in the directed issue has been set to SEK 25.04 per share.
The subscription price for shares in the directed issue related to LTIP 2024 corresponds, in accordance with the decision, to the volume-weighted average price of the Company's share on the Spotlight Stock Market during the trading period from February 21, 2024, to February 27, 2024.
The subscription price for TO 2 and TO 3 will be published in a separate press release.
For further information, please contact Ulrik Harrysson, CEO of SyntheticMR AB (publ).
Phone: +46 70 529 29 87
E-mail: ulrik.harrysson@syntheticmr.com.